Correction of Linezolid-Induced Myelotoxicity After Switch to Tedizolid in a Patient Requiring Suppressive Antimicrobial Therapy for Multidrug-Resistant Staphylococcus epidermidis Prosthetic-Joint Infection Accéder au pdf ► Ferry TBatailler CConrad ATriffault-Fillit CLaurent FValour FChidiac Con behalf of Lyon BJI Study Group Cas cliniques 2018 Open Forum Infect Dis. 2018 Sep 25;5(10):ofy246. doi: 10.1093/ofid/ofy246. eCollection 2018 Oct. Antimicrobial therapyLinezolidProsthetic joint infectionStaphylococcus epidermidisTedizolid
